Anesthetic management of glucose 6-phosphate dehydrogenase deficiency.

Rev Esp Anestesiol Reanim (Engl Ed)

Servicio de Anestesiología, Reanimación y Terapéutica del dolor, Hospital Universitario de Valme, Sevilla, Spain.

Published: April 2023

Glucose 6-phosphate dehydrogenase deficiency is the most common enzyme disease of red blood cells, with around 400 million people suffering from it throughout the world and linked to the X chromosome inheritance, thus it predominantly affects men. Glucose 6-phosphate-dehydrogenase participates in the pentose-phosphate pathway, being responsible for cellular metabolism and the production of antioxidants. A deficiency of this enzyme alters its ability to protect red blood cells from oxidative stress caused by certain drugs, metabolic conditions, infections and food. Specific anesthetic considerations are required to reduce the morbidity and mortality associated with medical-surgical interventions in patients with this disease. This article presents the case of a 45-year-old man with glucose 6-phosphate dehydrogenase deficiency who underwent combined general anaesthesia for programmed low anterior resection of the rectum.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.redare.2021.11.010DOI Listing

Publication Analysis

Top Keywords

glucose 6-phosphate
12
6-phosphate dehydrogenase
12
dehydrogenase deficiency
12
red blood
8
blood cells
8
anesthetic management
4
glucose
4
management glucose
4
deficiency
4
deficiency glucose
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!